Khatuna Gagnidze, Ph.D. - Publications

Affiliations: 
2007 Icahn School of Medicine at Mount Sinai, New York, NY, United States 
Area:
Neuroscience Biology, Biochemistry, Pharmacology

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Gomes I, Aryal DK, Wardman JH, Gupta A, Gagnidze K, Rodriguiz RM, Kumar S, Wetsel WC, Pintar JE, Fricker LD, Devi LA. GPR171 is a hypothalamic G protein-coupled receptor for BigLEN, a neuropeptide involved in feeding. Proceedings of the National Academy of Sciences of the United States of America. 110: 16211-6. PMID 24043826 DOI: 10.1073/pnas.1312938110  0.4
2011 Miller LK, Hou X, Rodriguiz RM, Gagnidze K, Sweedler JV, Wetsel WC, Devi LA. Mice deficient in endothelin-converting enzyme-2 exhibit abnormal responses to morphine and altered peptide levels in the spinal cord. Journal of Neurochemistry. 119: 1074-85. PMID 21972895 DOI: 10.1111/j.1471-4159.2011.07513.x  0.4
2011 Rozenfeld R, Gupta A, Gagnidze K, Lim MP, Gomes I, Lee-Ramos D, Nieto N, Devi LA. AT1R-CB₁R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II. The Embo Journal. 30: 2350-63. PMID 21540834 DOI: 10.1038/emboj.2011.139  0.4
2010 Ouimet T, Orng SV, Poras H, Gagnidze K, Devi LA, Fournié-Zaluski MC, Roques BP. Identification of an endothelin-converting enzyme-2-specific fluorigenic substrate and development of an in vitro and ex vivo enzymatic assay. The Journal of Biological Chemistry. 285: 34390-400. PMID 20807771 DOI: 10.1074/jbc.M110.120576  0.4
2008 Gagnidze K, Sachchidanand, Rozenfeld R, Mezei M, Zhou MM, Devi LA. Homology modeling and site-directed mutagenesis to identify selective inhibitors of endothelin-converting enzyme-2. Journal of Medicinal Chemistry. 51: 3378-87. PMID 18507370 DOI: 10.1021/jm7015478  0.4
2006 Breit A, Gagnidze K, Devi LA, Lagacé M, Bouvier M. Simultaneous activation of the delta opioid receptor (deltaOR)/sensory neuron-specific receptor-4 (SNSR-4) hetero-oligomer by the mixed bivalent agonist bovine adrenal medulla peptide 22 activates SNSR-4 but inhibits deltaOR signaling. Molecular Pharmacology. 70: 686-96. PMID 16682504 DOI: 10.1124/mol.106.022897  0.4
Show low-probability matches.